Pretreatment by omalizumab allows allergenāspecific immunotherapy in children and young adult with severe allergic asthma
Crossref DOI link: https://doi.org/10.1186/2045-7022-5-S2-P1
Published Online: 2015-03-23
Published Print: 2015-03-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lambert, Nathalie
Guiddir, Tamazoust
Just, Jocelyne
Amat, Flore
Version of Record valid from 2015-03-23
Article History
First Online: 23 March 2015